N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-({1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide
Chemical Structure Depiction of
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-({1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-({1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide
Compound characteristics
Compound ID: | G857-0122 |
Compound Name: | N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-({1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4-yl}sulfanyl)acetamide |
Molecular Weight: | 436.55 |
Molecular Formula: | C18 H24 N6 O3 S2 |
Smiles: | Cc1nnc(NC(CSC2C3CCCC=3N(CCN3CCOCC3)C(N=2)=O)=O)s1 |
Stereo: | ACHIRAL |
logP: | 0.6165 |
logD: | 0.5123 |
logSw: | -1.5611 |
Hydrogen bond acceptors count: | 10 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 82.856 |
InChI Key: | LWMPUYSGJYVGEJ-UHFFFAOYSA-N |